Magnesium sulfate therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Neurosurgery Quarterly

Volumn 19, Issue 1, 2009, Pages 35-39

  Akdemir, Hidayet ^a   Kulakszoǧlu, E Onur ^b   Tucer, Bülent ^b   Menkü, Ahmet ^b   Postalc, Lütfü ^a   Günald, Ömür ^a,c  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^c NONE   (Turkey)

Author keywords

Magnesium sulfate; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MAGNESIUM SULFATE; NIMODIPINE;

ADULT; ARTICLE; BOLUS INJECTION; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG MEGADOSE; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 67651181074     PISSN: 10506438     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNQ.0b013e31818d0ecf     Document Type: Article

References (34)

1. Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome, Review. Am J Med. 2002;112:58-66. (Pubitemid 34113856)
2. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery. 2000;47:602-606. (Pubitemid 32044706)
3. Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22:922-927.
4. Naidu S, Payne AJ, Moodley J, et al. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br J Obstet Gynaecol. 1996;103:111-116. (Pubitemid 26054523)
5. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia, Review. Stroke. 1989;20:1273-1275.
6. Spitzner R. Algumas consideraçoes sobre a bioquimica da açao benefica do magnesio. In: Spitzner R, ed. O Magnesio na Saude. 2nd ed. Curitiba: Editoria Universitaria Champagnat; 1999:65-78.
7. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
8. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysm. J Neurosurg. 1968;28:14-20.
9. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computed tomographic scanning. Neurosurgery. 1980;6:1-9.
10. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci. 2002;9:279-281.
11. Veyna RJ, Seyfried D, Burke DK, et al. Magnesium sulfate therapy after aneuyrsmal subarachnoid hemorrhage. J Neurosurg. 2002;96:510-514. (Pubitemid 34230205)
12. Kirmani JF, Yahia AM, Qureshi AI, et al. Pilot trial of safety and effectiveness of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in patients with aneursymal subarachnoid hemorrhage. American Association of Neurological Surgeons Annual Meeting, 2002.
13. Van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, et al. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir. 2003;145:195-199.
14. Barile M, van de Wyngaert F, Jativa M, et al. Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage. Intensive Care Med. 2003;29:1182-1185. (Pubitemid 36918566)
15. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345:1455-1463.
16. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201-205.
17. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med. 1994;96:63-76. (Pubitemid 24043654)
18. Altura BM, Altura BT. The role of magnesium in etiology of strokes and cerebral vasospasm. Magnesium. 1982;1:277-291.
19. Dyckner T, Wester PO. The relation between extra and intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand. 1978;204:269-282. (Pubitemid 9030044)
20. Pyne GJ, Cadoux-Hudson TA, Clark JF. Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg. 2001;15:409-415.
21. Muir KW. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness Review. CNS Drugs. 2001;15:921-930.
22. Tramer MR, Reynolds DJ, Moore RA, et al. Efficacy, doseresponse, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology. 1997;87:1277-1289.
23. Brewer RP, Parra A, Lynch J, et al. Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2001;13:202-206. (Pubitemid 32606414)
24. Prevedello DM, Cordeiro JG, de Morais AL, et al. Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surg Neurol. 2006;65(suppl):14-20, discussion S1:20-1:21.
25. Sviri GE, Lewis DH, Correa R, et al. Basilar artery vasospasm and delayed posterior circulation ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1867-1872. (Pubitemid 38971867)
26. Van den Bergh WM, Algra A, van Kooten F, et al; MASH Study Group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011-1015.
27. Ross N, Hutchinson PJ, Seeley H, et al. Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study. J Neurol Neurosurg Psychiatry. 2002;72:480-484. (Pubitemid 34289564)
28. Molyneux A, Kerr R, Stratton I, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
29. Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry. 2004;75:868-872.
30. Arsenian MA. Magnesium and cardiovascular disease, Review. Prog Cardiovasc Dis. 1993;35:271-310.
31. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636-642. (Pubitemid 19088521)
32. Fuchs-Buder T, Wilder-Smith OH, Borgeat A, et al. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block. Br J Anaesth. 1995;74:405-409.
33. Crozier TA, Radke J, Weyland A, et al. Haemodynamic and endocrine effects of deliberate hypotension with magnesium sulphate for cerebral-aneurysm surgery. Eur J Anaesthesiol. 1991;8:115-121.
34. Scardo JA, Hogg BB, Newman RB. Favorable hemodynamic effects of magnesium sulfate in preeclampsia. Am J Obstet Gynecol. 1995;173:1249-1253.